Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer

Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer

US Patent 12168696 · Granted Dec 17, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Constructs specifically recognizing Glypican 3 and uses thereof2025
Anti-MUC16 antibodies and uses thereof2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
2-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitors2025
Antibodies to galectin-3 and methods of use thereof2024
Constructs targeting prostate-specific membrane antigen (PSMA) and uses thereof2024
Antibody agents specific for human CD19 and uses thereof2024
Antibody/T-cell receptor chimeric constructs and uses thereof2024
Cells expressing chimeric activating receptors and chimeric stimulating receptor2024
Antibodies to MUC16 and methods of use thereof2023
Constructs trageting CD22 and uses thereof2023
Constructs trageting CD22 and uses thereof2023